Diabetes drug may help to prolong preterm pregnancies in women with pre-eclampsia

pregnancy
Credit: CC0 Public Domain

Giving the drug metformin to women diagnosed with preterm pre-eclampsia may help to prolong pregnancy (gestation), finds a study published by The BMJ today.

The findings show that pregnancy was prolonged by a week in the treatment group compared with the no treatment group, but the result was not statistically significant and therefore points to the need for further study.

If confirmed by future research, this could have important benefits for both mother and baby.

Pre-eclampsia is a serious condition thought to be caused by the placenta not developing properly. Preterm (between 26-32 weeks’ gestation) often leads to early delivery, putting babies at risk of serious disability and death, particularly in low and .

Metformin is usually given to patients with diabetes to help control blood sugar levels, but preliminary studies suggest it could also be a potential treatment for pre-eclampsia.

So researchers in Australia and South Africa set out to evaluate whether extended release metformin could be used to prolong gestation in women diagnosed with preterm pre-eclampsia.

The trial took place at a large hospital in Cape Town, South Africa and involved 180 undergoing close monitoring (expectant management) for preterm pre-eclampsia.

Women were recruited between February 2018 and March 2020 when they were, on average, 29 weeks’ pregnant. None of them had diabetes or were currently using metformin or any other drugs that might interact with it.

Women were randomly split into two groups (arms): 90 received extended release metformin and 90 received placebo daily, until delivery.

The average time from randomisation to delivery was 17.7 days in the metformin arm and 10.1 days in the placebo arm, an average difference of 7.6 days. However, this difference was not statistically significant.

Two more analyses were carried out. The first (in women who continued to take metformin at any dose) showed an average 9.6 day longer gestation, and the second (in women who took the full dose of metformin) showed an average 11.5 day longer gestation. Both these results were statistically significant.

There were no differences between the two arms in terms of serious birth complications or death among both mothers and babies. And no serious adverse events were observed, although diarrhoea was more common in the metformin arm.

This is a robust and well designed trial, but the researchers acknowledge some limitations. For example, this was a single centre study where the women had a high incidence of HIV, obesity, and chronic hypertension, so the results may not be more widely applicable.

Further trials of metformin should be considered to confirm whether the drug can statistically significantly prolong gestation and to evaluate the benefits to newborns, they say. However, based on the findings of this study, “we are cautiously optimistic that extended release prolongs gestation in with preterm pre-eclampsia.”



More information: Use of metformin to prolong gestation in preterm pre-eclampsia: randomised, double blind, placebo controlled trial, BMJ (2021). DOI: 10.1136/bmj.n2103 , www.bmj.com/content/374/bmj.n2103

Citation: Diabetes drug may help to prolong preterm pregnancies in women with pre-eclampsia (2021, September 22) retrieved 5 October 2021 from https://medicalxpress.com/news/2021-09-diabetes-drug-prolong-preterm-pregnancies.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Female fertility: Why lifestyle choices count thumbnail

Female fertility: Why lifestyle choices count

Female fertility: Why lifestyle choices countLifestyle choices can affect a woman's ability to conceive. Consider some simple steps if you hope to get pregnant.By Mayo Clinic Staff If you're hoping to get pregnant, you might wonder about your fertility and whether you can improve it. Some factors might be beyond your control, such as medical
Read More
Teachers without a green mark, not vaccinated and refusing tests will not be allowed to teach thumbnail

Teachers without a green mark, not vaccinated and refusing tests will not be allowed to teach

משרד החינוך הנחה הבוקר (ה') את מנהלי כל מוסדות החינוך שלא להתיר כניסה לבתי הספר ולגני הילדים של עובדי הוראה, מורים, גננות וסייענים שאינם בעלי תו ירוק. בהנחיה נאמר גם כי היעדרותם של עובדים אלה - הלא מחוסנים או המסרבים להציג בדיקת קורונה שלילית - תיחשב כהיעדרות מהעבודה שאינה מוצדקת ולכן איננה מזכה בקבלת שכר.…
Read More
US Federal Reserve to raise interest rates as early as next year thumbnail

US Federal Reserve to raise interest rates as early as next year

물가상승률 목표치 두배 이상 뛰자 제로금리 방침 유지 속 “곧 테이퍼링” 미국 워싱턴DC에 위치한 연방준비제도 청사 전경. 뉴욕 신화=연합뉴스 미국 중앙은행인 연방준비제도(Fed·연준)가 22일(현지시간) 자산매입 축소(테이퍼링)를 곧 시작할 수 있다고 밝혔다. 테이퍼링 개시 신호가 더욱 분명해지는 흐름이다. ‘제로 금리’ 방침은 유지했지만 금리 인상 시기가 이르면 내년으로 빨라질 가능성도 시사했다. 연준은 이날 연방공개시장위원회(FOMC) 정례회의를 마친 뒤 성명을…
Read More
Adopting cloud-first policy, upskilling among ways to further cloud adoption in APAC: report thumbnail

Adopting cloud-first policy, upskilling among ways to further cloud adoption in APAC: report

A report published yesterday has offered recommendations on how public health systems in Asia-Pacific can address roadblocks in adopting cloud technologies. Titled "Overcoming Barriers to Cloud Adoption in Public Healthcare in Asia Pacific", the report was developed by AWS Institute, the thought leadership programme of Amazon Web Services, in partnership with health innovation advisory firm…
Read More
Index Of News
Consider making some contribution to keep us going. We are donation based team who works to bring the best content to the readers. Every donation matters.
Donate Now

Subscription Form

Liking our Index Of News so far? Would you like to subscribe to receive news updates daily?

Total
0
Share